This chapter identifies and discusses recommendations and contraindications to various drugs in pregnancy and lactation. When treatment with one of these drugs is essential, data must be carefully examined and evaluated, so that a risk–benefit ratio may be determined. In addition, the benefits of breastfeeding are numerous, so any decision to limit breastfeeding must be justified by the fact that the risk to the baby clearly outweighs the benefits offered by breastfeeding. It is crucial to have both patient and physician take part in the decision-making process.
|Original language||English (US)|
|Title of host publication||Comprehensive Dermatologic Drug Therapy, Fourth Edition|
|State||Published - Jan 1 2020|
ASJC Scopus subject areas